|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
138,140,000 |
Market
Cap: |
142.28(M) |
Last
Volume: |
3,241,097 |
Avg
Vol: |
3,323,049 |
52
Week Range: |
$0.937 - $1.235 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 807 |
Guru Rank Value : 1 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Spectrum Pharmaceuticals is a biopharmaceutical company. Co. is engaged in acquiring, developing, and commercializing targeted oncology therapies. Co. has two drugs in late-stage development: Eflapegrastim, which is a long-acting granulocyte colony-stimulating factor for the treatment of chemotherapy-induced neutropenia; as well as Poziotinib, which is an irreversible tyrosine kinase inhibitor under investigation for non-small cell lung cancer tumors with various mutations.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
50,000 |
Total Buy Value |
$0 |
$0 |
$0 |
$22,500 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
1 |
Total Shares Sold |
0 |
0 |
32,387 |
490,738 |
Total Sell Value |
$0 |
$0 |
$35,496 |
$343,474 |
Total People Sold |
0 |
0 |
1 |
7 |
Total Sell Transactions |
0 |
0 |
1 |
19 |
End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Shrotriya Rajesh C Md |
Director |
|
2018-04-25 |
4 |
AS |
$17.26 |
$517,800 |
I/I |
(30,000) |
999,977 |
|
- |
|
Shrotriya Rajesh C Md |
Director |
|
2018-04-24 |
4 |
AS |
$18.11 |
$543,300 |
I/I |
(30,000) |
1,029,977 |
|
- |
|
Shrotriya Rajesh C Md |
Director |
|
2018-04-23 |
4 |
AS |
$18.37 |
$551,100 |
I/I |
(30,000) |
1,059,977 |
|
- |
|
Shrotriya Rajesh C Md |
Director |
|
2018-04-20 |
4 |
AS |
$18.67 |
$560,100 |
I/I |
(30,000) |
1,089,977 |
|
- |
|
Shrotriya Rajesh C Md |
Director |
|
2018-04-19 |
4 |
AS |
$19.18 |
$575,400 |
I/I |
(30,000) |
1,119,977 |
|
- |
|
Shrotriya Rajesh C Md |
Director |
|
2018-04-18 |
4 |
AS |
$19.71 |
$591,300 |
I/I |
(30,000) |
1,149,977 |
|
- |
|
Turgeon Joseph W. |
CEO & President |
|
2018-04-17 |
4 |
AS |
$19.00 |
$219,751 |
D/D |
(11,565) |
316,509 |
|
- |
|
Shrotriya Rajesh C Md |
Director |
|
2018-04-17 |
4 |
AS |
$18.56 |
$556,800 |
I/I |
(30,000) |
1,179,977 |
|
- |
|
Riga Thomas J |
EVP, COO & CCO |
|
2018-04-17 |
4 |
AS |
$19.07 |
$35,083 |
D/D |
(1,840) |
243,854 |
|
- |
|
Shrotriya Rajesh C Md |
Director |
|
2018-04-16 |
4 |
AS |
$18.72 |
$561,600 |
I/I |
(30,000) |
1,209,977 |
|
- |
|
Riga Thomas J |
EVP, COO & CCO |
|
2018-04-16 |
4 |
AS |
$18.60 |
$72,521 |
D/D |
(3,900) |
254,694 |
|
- |
|
Shrotriya Rajesh C Md |
Director |
|
2018-04-13 |
4 |
AS |
$19.93 |
$597,900 |
I/I |
(30,000) |
1,239,977 |
|
- |
|
Shrotriya Rajesh C Md |
Director |
|
2018-04-12 |
4 |
AS |
$20.72 |
$621,600 |
I/I |
(30,000) |
1,269,977 |
|
- |
|
Shrotriya Rajesh C Md |
Director |
|
2018-04-11 |
4 |
AS |
$20.30 |
$609,000 |
I/I |
(30,000) |
1,299,977 |
|
- |
|
Shrotriya Rajesh C Md |
Director |
|
2018-04-10 |
4 |
AS |
$17.74 |
$532,200 |
I/I |
(30,000) |
1,329,977 |
|
- |
|
Shrotriya Rajesh C Md |
Director |
|
2018-04-09 |
4 |
AS |
$15.01 |
$184,623 |
I/I |
(12,300) |
1,359,977 |
|
- |
|
Shrotriya Rajesh C Md |
Director |
|
2018-04-06 |
4 |
AS |
$15.00 |
$55,290 |
I/I |
(3,686) |
1,372,277 |
|
- |
|
Shrotriya Rajesh C Md |
Director |
|
2018-04-05 |
4 |
AS |
$15.33 |
$459,900 |
I/I |
(30,000) |
1,375,963 |
|
- |
|
Shrotriya Rajesh C Md |
Director |
|
2018-04-04 |
4 |
AS |
$15.01 |
$450,300 |
I/I |
(30,000) |
1,405,963 |
|
- |
|
Shrotriya Rajesh C Md |
Director |
|
2018-04-03 |
4 |
AS |
$15.14 |
$454,200 |
I/I |
(30,000) |
1,435,963 |
|
- |
|
Shrotriya Rajesh C Md |
Director |
|
2018-04-02 |
4 |
AS |
$15.61 |
$468,300 |
I/I |
(30,000) |
1,465,963 |
|
- |
|
Riga Thomas J |
Chief Operating Officer |
|
2018-04-02 |
4 |
AS |
$15.58 |
$30,350 |
D/D |
(1,948) |
256,452 |
|
- |
|
Shrotriya Rajesh C Md |
Director |
|
2018-03-29 |
4 |
AS |
$16.18 |
$485,400 |
I/I |
(30,000) |
1,495,963 |
|
- |
|
Shrotriya Rajesh C Md |
Director |
|
2018-03-28 |
4 |
AS |
$16.19 |
$485,700 |
I/I |
(30,000) |
1,525,963 |
|
- |
|
Turgeon Joseph W. |
CEO & President |
|
2018-03-28 |
4 |
AS |
$16.40 |
$78,884 |
D/D |
(4,810) |
328,074 |
|
- |
|
658 Records found
|
|
Page 12 of 27 |
|
|